NASDAQ:MDXG MiMedx Group (MDXG) Stock Price, News & Analysis $5.90 +0.09 (+1.55%) As of 01:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About MiMedx Group Stock (NASDAQ:MDXG) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get MiMedx Group alerts:Sign Up Key Stats Today's Range$5.80▼$5.9450-Day Range$5.81▼$7.4352-Week Range$5.47▼$10.14Volume248,009 shsAverage Volume679,768 shsMarket Capitalization$871.43 millionP/E Ratio21.85Dividend YieldN/APrice Target$12.50Consensus RatingBuy Company OverviewMiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.Read More… MiMedx Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks63rd Percentile Overall ScoreMDXG MarketRank™: MiMedx Group scored higher than 63% of companies evaluated by MarketBeat, and ranked 350th out of 924 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMiMedx Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageMiMedx Group has received no research coverage in the past 90 days.Read more about MiMedx Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth6.67% Earnings GrowthEarnings for MiMedx Group are expected to grow by 6.67% in the coming year, from $0.30 to $0.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of MiMedx Group is 21.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.62.Price to Earnings Ratio vs. SectorThe P/E ratio of MiMedx Group is 21.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.71.Price to Book Value per Share RatioMiMedx Group has a P/B Ratio of 4.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about MiMedx Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.58% of the float of MiMedx Group has been sold short.Short Interest Ratio / Days to CoverMiMedx Group has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in MiMedx Group has recently decreased by 2.99%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMiMedx Group does not currently pay a dividend.Dividend GrowthMiMedx Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.58% of the float of MiMedx Group has been sold short.Short Interest Ratio / Days to CoverMiMedx Group has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in MiMedx Group has recently decreased by 2.99%, indicating that investor sentiment is improving. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for MDXG on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added MiMedx Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, MiMedx Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,268,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.70% of the stock of MiMedx Group is held by insiders.Percentage Held by Institutions79.15% of the stock of MiMedx Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about MiMedx Group's insider trading history. Receive MDXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiMedx Group and its competitors with MarketBeat's FREE daily newsletter. Email Address MDXG Stock News HeadlinesAnalyzing Alpha Tau Medical (NASDAQ:DRTS) & MiMedx Group (NASDAQ:MDXG)June 14, 2025 | americanbankingnews.comMIMEDX to Participate in Upcoming Investor ConferencesMay 27, 2025 | globenewswire.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. June 23, 2025 | Porter & Company (Ad)Monday 5/5 Insider Buying Report: MDXG, HLMNMay 7, 2025 | nasdaq.comZooming In On MiMedx Group's EarningsMay 7, 2025 | finance.yahoo.comMIMEDX to Present at the BofA Securities 2025 Healthcare ConferenceMay 6, 2025 | globenewswire.comMIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)May 5, 2025 | globenewswire.comUS$12.20: That's What Analysts Think MiMedx Group, Inc. (NASDAQ:MDXG) Is Worth After Its Latest ResultsMay 3, 2025 | finance.yahoo.comSee More Headlines MDXG Stock Analysis - Frequently Asked Questions How have MDXG shares performed this year? MiMedx Group's stock was trading at $9.62 at the beginning of 2025. Since then, MDXG shares have decreased by 38.8% and is now trading at $5.8850. View the best growth stocks for 2025 here. How were MiMedx Group's earnings last quarter? MiMedx Group, Inc (NASDAQ:MDXG) issued its quarterly earnings data on Wednesday, April, 30th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. The company had revenue of $88.21 million for the quarter, compared to analysts' expectations of $86.32 million. MiMedx Group had a trailing twelve-month return on equity of 22.70% and a net margin of 11.40%. Read the conference call transcript. Who are MiMedx Group's major shareholders? Top institutional shareholders of MiMedx Group include Trigran Investments Inc. (5.15%), Vanguard Group Inc. (4.54%), Paradigm Capital Management Inc. NY (3.17%) and First Light Asset Management LLC (2.34%). Insiders that own company stock include Joseph H Capper, William Frank Iv Hulse, Rohit Kashyap, Ricci S Whitlow, Robert Benjamin Stein, Kimberly Maersk-Moller, William Lawrence Phelan and Rice Doug. View institutional ownership trends. How do I buy shares of MiMedx Group? Shares of MDXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of MiMedx Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that MiMedx Group investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Hawkins (HWKN), Adobe (ADBE) and GE Aerospace (GE). Company Calendar Last Earnings4/30/2025Today6/23/2025Next Earnings (Estimated)7/30/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryMedical Equipment Current SymbolNASDAQ:MDXG CIK1376339 Webwww.mimedx.com Phone(770) 651-9100Fax678-384-6741Employees870Year FoundedN/APrice Target and Rating Average Stock Price Target$12.50 High Stock Price Target$13.00 Low Stock Price Target$12.00 Potential Upside/Downside+115.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$0.27 Trailing P/E Ratio21.52 Forward P/E Ratio19.37 P/E GrowthN/ANet Income$42.42 million Net Margins11.40% Pretax Margin15.47% Return on Equity22.70% Return on Assets16.77% Debt Debt-to-Equity Ratio0.09 Current Ratio4.70 Quick Ratio4.13 Sales & Book Value Annual Sales$348.88 million Price / Sales2.46 Cash Flow$0.33 per share Price / Cash Flow17.54 Book Value$1.31 per share Price / Book4.44Miscellaneous Outstanding Shares147,700,000Free Float145,191,000Market Cap$858.14 million OptionableOptionable Beta1.83 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:MDXG) was last updated on 6/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.